Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Pagnin

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Nephrology|September 14, 2002
Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipineL Calò, B Giacon, P A Davis, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patientsL A Calò, L Stanic, P A Davis, et al.
Clinical Nephrology|December 2, 2004
Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis--a molecular biological approachL A Calò, A Naso, E Pagnin, et al.
Clinical Nephrology|May 16, 2000
Oxidative stress and nitric oxide system in post-transplant hypertensionL Calò, R Marcon, P Rigotti, et al.
Kidney International|September 5, 2001
Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromesL Calò, G Ceolotto, M Milani, et al.
Journal of Endocrinological Investigation|July 17, 2009
High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?L A Calò, R Montisci, R Scognamiglio, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 30, 2015
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trialS Vigili de Kreutzenberg, G Ceolotto, A Cattelan, et al.
Clinical and Experimental Rheumatology|June 7, 2011
Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitisB Molena, P Sfriso, F Oliviero, et al.
Reumatismo|January 12, 2007
[Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee]U Fiocco, P Sfriso, F Oliviero, et al.
Autoimmunity Reviews|July 13, 2010
Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitisU Fiocco, P Sfriso, F Lunardi, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Nephrology|September 14, 2002
Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipineL Calò, B Giacon, P A Davis, et al.
International Journal of Clinical Pharmacology and Therapeutics|June 5, 2003
Effect of epoetin on HO-1 mRNA level and plasma antioxidants in hemodialysis patientsL A Calò, L Stanic, P A Davis, et al.
Clinical Nephrology|December 2, 2004
Vitamin E-coated dialyzers reduce oxidative stress related proteins and markers in hemodialysis--a molecular biological approachL A Calò, A Naso, E Pagnin, et al.
Clinical Nephrology|May 16, 2000
Oxidative stress and nitric oxide system in post-transplant hypertensionL Calò, R Marcon, P Rigotti, et al.
Kidney International|September 5, 2001
Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromesL Calò, G Ceolotto, M Milani, et al.
Journal of Endocrinological Investigation|July 17, 2009
High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?L A Calò, R Montisci, R Scognamiglio, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 30, 2015
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trialS Vigili de Kreutzenberg, G Ceolotto, A Cattelan, et al.
Clinical and Experimental Rheumatology|June 7, 2011
Synovial colony-stimulating factor-1 mRNA expression in diffuse pigmented villonodular synovitisB Molena, P Sfriso, F Oliviero, et al.
Reumatismo|January 12, 2007
[Intra-articular treatment with the TNF-alpha antagonist, etanercept, in severe diffuse pigmented villonodular synovitis of the knee]U Fiocco, P Sfriso, F Oliviero, et al.
Autoimmunity Reviews|July 13, 2010
Molecular pathways involved in synovial cell inflammation and tumoral proliferation in diffuse pigmented villonodular synovitisU Fiocco, P Sfriso, F Lunardi, et al.
Pageof 2